Suppr超能文献

肝素诱导的脂解活性对大鼠高密度脂蛋白结构的影响。

Effects of heparin-induced lipolytic activity on the structure of rat high-density lipoprotein.

作者信息

Swaney J B, Orishimo M W

机构信息

Department of Biological Chemistry, Hahnemann University, Philadelphia, PA 19102.

出版信息

Biochim Biophys Acta. 1989 Apr 26;1002(3):338-47. doi: 10.1016/0005-2760(89)90348-2.

Abstract

Following its secretion into the plasma compartment, the high-density lipoprotein (HDL) is presumed to be acted upon by both soluble enzymes, such as lecithin:cholesterol acyltransferase (LCAT), and membrane-associated enzymes, such as lipoprotein lipase and hepatic lipase. Rats were injected intravenously with heparin to release membrane-associated lipolytic activities into the circulation and the collected plasma was incubated overnight at 37 degrees C in the presence or absence of an LCAT inhibitor or an inhibitor of lipoprotein lipase (1 M NaCl). It was observed that lipoprotein lipase accounted for most of the triglyceride hydrolase activity in the heparin-treated plasma, and that the heparin-releasable activities caused an increase in HDL density but no measurable change in particle size when LCAT was inhibited. Heparin treatment caused about a 60% decrease in plasma triacylglycerol during the interval between injection of heparin and blood collection. Although this caused marked compositional changes in the d less than 1.063 g/ml lipoproteins, no changes were observed in the lipid composition or apoprotein distribution in the HDL. Subsequent incubation for 18 h at 37 degrees C produced marked increases in the apoE content of HDL from heparin-treated plasma even when LCAT was inhibited. Time-course studies showed that in the presence of an LCAT inhibitor there was considerable conversion of phosphatidylcholine to lysophosphatidylcholine in heparin-treated plasma, and that this activity was diminished by 1 M NaCl, but that no phospholipolysis was observed in control plasma. By contrast, both heparin-treated and control plasma possessed substantial triglyceride hydrolase activity. The concurrent action of lipases and LCAT was observed to reduce the maximum level of cholesterol esterification which could be achieved in the absence of lipase activity. It is concluded that changes in HDL particle size are mainly attributable to LCAT, but that lipase activities, which are either free in rat plasma or releasable by heparin, play a role in restructuring the phospholipid moiety and altering the protein composition of the HDL, especially with respect to apoE, a potential ligand to cellular receptors.

摘要

高密度脂蛋白(HDL)分泌到血浆中后,推测它会受到可溶性酶(如卵磷脂胆固醇酰基转移酶(LCAT))和膜相关酶(如脂蛋白脂肪酶和肝脂肪酶)的作用。给大鼠静脉注射肝素,以将膜相关的脂解活性释放到循环中,并将收集的血浆在37℃下在有或没有LCAT抑制剂或脂蛋白脂肪酶抑制剂(1M NaCl)的情况下孵育过夜。观察到脂蛋白脂肪酶占肝素处理血浆中大多数甘油三酯水解酶活性,并且当LCAT被抑制时,肝素可释放的活性导致HDL密度增加,但颗粒大小没有可测量的变化。肝素处理在注射肝素和采血之间的间隔期间使血浆三酰甘油降低约60%。尽管这导致密度小于1.063 g/ml的脂蛋白的组成发生明显变化,但在HDL的脂质组成或载脂蛋白分布中未观察到变化。随后在37℃下孵育18小时,即使LCAT被抑制,肝素处理血浆中HDL的载脂蛋白E含量也会显著增加。时间进程研究表明,在存在LCAT抑制剂的情况下,肝素处理血浆中磷脂酰胆碱大量转化为溶血磷脂酰胆碱,并且该活性被1M NaCl减弱,但在对照血浆中未观察到磷脂分解。相比之下,肝素处理血浆和对照血浆都具有大量的甘油三酯水解酶活性。观察到脂肪酶和LCAT的共同作用降低了在没有脂肪酶活性的情况下可以达到的胆固醇酯化的最大水平。得出的结论是,HDL颗粒大小的变化主要归因于LCAT,但在大鼠血浆中游离或可被肝素释放的脂肪酶活性在重组HDL的磷脂部分和改变其蛋白质组成方面发挥作用,特别是对于载脂蛋白E,它是细胞受体的潜在配体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验